DKR has been converting and selling since the anniversary of their deal at the end of Nov 2006. They have 6 months in all before their convertibles can be resumed at 103% of cost or $3.0385/share. Since they are likely to stay in the money then all their notes will be converted in that time. To date they have sold all and that has represented 76% of all activity. Take away the churning whereby people lock in CGT events without changing net holdings and the non-DKR selling amounts to almost nothing in 3 months. It appears then that virtually all holders are fully aware of the situation with no-one selling and a few simply acquiring DKR shares as they become available and for as low a price as possible. By the time managementand CS start the pre-IPO PR blitz the overhang should be reduced to an unimportant level. Management wants the shareprice reached pre-IPO to approach the level expected from the valuation analysis to be released in the prospectus.
- Forums
- ASX - By Stock
- impact of dkr selling
TZL
tz limited
Add to My Watchlist
0.00%
!
5.3¢

DKR has been converting and selling since the anniversary of...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
5.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.87M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 26781 | 5.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.4¢ | 34816 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 26781 | 0.053 |
1 | 150000 | 0.052 |
1 | 100000 | 0.051 |
1 | 100000 | 0.048 |
1 | 39888 | 0.022 |
Price($) | Vol. | No. |
---|---|---|
0.054 | 34816 | 3 |
0.055 | 20000 | 1 |
0.060 | 100000 | 1 |
0.063 | 10000 | 1 |
0.064 | 50055 | 1 |
Last trade - 16.21pm 04/07/2025 (20 minute delay) ? |
Featured News
TZL (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online